Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.02 -0.34 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.36 | 52 Week High | $8.22 | |||
| Open | $58.15 | 52 Week Low | $3.07 | |||
| Day High | $58.40 | P/E | N/A | |||
| Day Low | $56.56 | EPS | $-1.30 | |||
| Volume | 871,821 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.73 -0.45 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.18 | 52 Week High | $63.73 | |||
| Open | $17.94 | 52 Week Low | $8.00 | |||
| Day High | $18.12 | P/E | N/A | |||
| Day Low | $17.16 | EPS | $-5.69 | |||
| Volume | 1,285,459 | |||||
